G

GE Healthcare

Imaging, monitoring, and healthcare IT solutions

HSE Advisor, External Environment

Full-TimePosted on 10/21/2026
No salary listed
Mid
Bachelor's, Master's
Lindesnes Municipality, Norway
In Person
Facilities OperationsEnvironmental Health & Safety

About the job

Requirements
  • A bachelor's or master's degree in ecotoxicology, environmental chemistry, environmental science, chemistry, biology, natural sciences, process technology, or another relevant field.
  • Relevant knowledge of the properties, dispersion, and potential environmental effects of chemicals.
  • Understanding of how environmental and ecotoxicological data are used in environmental risk assessment.
  • Good digital skills.
  • Good oral and written Norwegian skills.
  • Good oral and written English skills.
  • Relevant experience is advantageous but not a prerequisite.
  • Interest in environmental science, chemicals, and ecotoxicology.
  • Ability to combine technical data with practical assessments.
  • Initiative and a structured, systematic approach to following up tasks.
  • Ability to work independently and collaborate across disciplines and organizational levels.
  • Ability to communicate complex environmental issues clearly.
  • Interest in developing personal expertise and environmental work practices.
Responsibilities
  • Contribute to the development and compliance of the company's environmental management system.
  • Assess HSE and external environmental impacts of changes to facilities, processes, and activities.
  • Conduct environmental risk assessments and environmental aspect analyses for existing production, projects, expansions, and the introduction of new products and chemicals.
  • Assess the environmental properties of chemicals and their potential effects, using ecotoxicological data as a basis for environmental risk assessments.
  • Contribute to assessments of emissions to water, air, and soil, including potential impacts on receiving environments.
  • Obtain, interpret, and apply relevant ecotoxicological information in chemical assessments, emissions evaluations, and environmental risk assessments.
  • Help ensure compliance with discharge permits, environmental regulations, government requirements, and internal environmental requirements.
  • Stay current with relevant environmental regulations, government requirements, and international standards, and conduct compliance assessments.
  • Participate in planning and implementing environmental improvement measures and projects.
  • Contribute to ongoing monitoring and development of the facility's environmental control and monitoring program.
  • Quality-check and assess environmental data and contribute to reporting to authorities and internally.
  • Provide support and expert advice on environmental issues to production, maintenance, project teams, and other relevant functions.
  • Facilitate and lead investigations and root-cause analyses, and follow up on environmental incidents and deviations.
  • Participate in internal audits, verifications, and improvement work.
  • Participate in relevant working groups, projects, and professional networks.
Desired Qualifications
  • Experience with ecotoxicological assessments and evaluating the effects of chemicals on the external environment.
  • Experience interpreting and applying environmental and ecotoxicological data.
  • Experience with environmental risk assessments, environmental aspect analyses, and environmental impact assessments.
  • Experience assessing and monitoring emissions to water, air, or soil.
  • Knowledge of environmental regulations, discharge permits, and government requirements.
  • Experience communicating with authorities and reporting to them.
  • Experience with environmental management and management systems, such as ISO 14001.
  • Experience in process industries, chemical industries, manufacturing, or project work.
  • Experience with audits, investigations, and systematic improvement work.

About the company

GE Healthcare Systems provides medical technologies and digital infrastructure to improve diagnosis, treatment, and monitoring of patients. Its products include imaging systems, mobile diagnostic devices, patient monitoring tools, and healthcare IT software that work together as hardware, software, and services to support hospitals, clinics, and researchers. The company differentiates itself with a large, integrated ecosystem, strong focus on AI analytics, and a global service network backed by substantial R&D investment. Its goal is to improve patient outcomes and the efficiency of healthcare delivery by enabling accurate diagnoses, effective treatments, and scaled operations.

Company Size

1-10

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

1892

Get referred to GE Healthcare

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 orders rose 11% and backlog reached a record $23.9 billion.
  • CareIntellect for Operations launched September 2026 with Duke Health and Queen's Health Systems.
  • CE mark and FDA progress for Photonova Spectra expand 2026-2027 commercial momentum.

What critics are saying

  • FDA logged multiple 2026 Class 2 recalls, including AW Server and telemetry systems.
  • Patient Care Solutions remained weak in Q2 2026; management is reviewing a sale.
  • SOFIE closes only after 2027 regulatory approvals; PET supply integration can slip badly.

What makes GE Healthcare unique

  • GE HealthCare combines imaging hardware, radiopharmaceuticals, and workflow software across hospitals.
  • Photonova Spectra and Vivid 2026 show premium innovation plus AI-enabled clinical automation.
  • SOFIE's 21 cyclotrons extend GE HealthCare into radiotracer manufacturing, not just scanners.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Tuition Reimbursement
  • Relocation Assistance

Company News

Yahoo Finance
Oct 23rd, 2026
Cash-rich stocks: Clean Harbors worth watching, UPS and GE HealthCare best avoided

StockStory has named one cash-generating stock worth a closer look and two it would avoid, arguing that strong cash flow does not always mean strong returns. Clean Harbors (NYSE:CLH) is the pick. Its revenue grew 13.5% a year over five years, and earnings per share rose 21.6% a year, helped by share buybacks. Its free cash flow margin is 8.8%, up 5.9 percentage points over five years. The shares trade at $320.91, or 30.7x forward earnings. StockStory would steer clear of United Parcel Service (NYSE:UPS) and GE HealthCare (NASDAQ:GEHC). UPS sales were flat over five years while earnings per share fell 8.4% a year. GE HealthCare faces projected sales growth of 4.4% and a 1.7-point drop in adjusted operating margin.

Associated Press
Oct 20th, 2026
GE HealthCare launches five-institution global trial of StarGuide GX theranostics SPECT/CT system

GE HealthCare has launched a clinical evaluation program for StarGuide GX, its next-generation digital 4D SPECT/CT system. Five institutions across three continents will take part. They are Hadassah Medical Center and Rambam Health Care Campus in Israel, Mayo Clinic in the US, Oncopole Claudius Regaud in France, and Peking University First Hospital in China. Each will assess image quality, quantitative performance, dynamic imaging, and workflow, and give feedback to guide the system's development. StarGuide GX uses dual-sided cadmium zinc telluride detectors and a dual-collimator design meant to remove manual collimator changes. It also uses NVIDIA RTX accelerated computing for image reconstruction. The system received CE Mark in November 2025 and is on sale in select EU states. Its US Food and Drug Administration 510(k) clearance is pending.

Yahoo Finance
Oct 19th, 2026
GE HealthCare launches LOGIQ Focus ultrasound with AI tools, 26% faster scans

GE HealthCare has launched LOGIQ Focus, a new general imaging ultrasound system in its LOGIQ family. The company announced the product in Chicago on October 19, 2026. The system runs on cSound Architecture and pairs high-definition imaging with AI-enabled tools. One of them, Auto Preset Assistant, detects the anatomy being scanned and activates the matching preset, saving up to five clicks per exam. In a third-party study, 90% of participants rated its image quality as excellent. The system was 26% faster than the predicate system. LOGIQ Focus is 510(k) cleared and CE Marked. GE HealthCare expects it and several other new products to add 1% to 2% to revenue growth, following more than $5 billion in innovation investment since 2023.

Business Wire
Oct 5th, 2026
GE HealthCare to acquire SOFIE Biosciences for $945M to expand US radiopharmaceutical supply

GE HealthCare has agreed to acquire SOFIE Biosciences, a US-based contract manufacturer of PET radiopharmaceuticals, for $945 million in cash. The deal with seller Trilantic North America is expected to close in the first half of 2027, subject to regulatory approvals. SOFIE Biosciences operates 15 contract manufacturing sites with 21 cyclotrons across the US, plus a theranostics-focused development and manufacturing facility. The acquisition establishes GE HealthCare's presence in the time-critical "final mile" of US PET radiopharmaceutical supply. The PET radiopharmaceutical market is expanding rapidly with approximately 20 PET radiotracers and over 30 radiotherapeutics currently under development. SOFIE Biosciences' portfolio includes a Phase III FAPI asset for which GE HealthCare already holds non-US rights. GE HealthCare estimates the transaction will be accretive to revenue growth, earnings margin, and earnings per share in the first full year of ownership.

PR Newswire
Sep 30th, 2026
AsiaMedic first in ASEAN to deploy GE HealthCare's MR31 deep learning MRI platform

AsiaMedic has become the first site in ASEAN to implement MR31, GE HealthCare's latest generation MRI platform featuring deep learning technology. The Singapore-based imaging centre is among the earliest adopters in Asia Pacific. MR31 incorporates deep learning technologies that reduce scan times and enable detailed examinations across neurological, musculoskeletal and nerve imaging. Sonic DL for 3D delivers up to 12 times scan acceleration, reducing examination times across brain, spine, orthopaedic and body scans. The platform also supports high-quality prostate MRI imaging. AIR Recon DL Phase Correction provides improved visualisation of clinically significant lesions, whilst high-resolution T2-weighted imaging aids lesion localisation for prostate fusion biopsy planning. Shorter scan times mean reduced patient time in scanners and may help decrease repeat examinations caused by movement.